List of Tables
Table 1. Global Anti-Parkinson Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Dopaminergic
Table 3. Key Players of Dopamine Agonists
Table 4. Key Players of Enzyme Inhibitors
Table 5. Key Players of Others
Table 6. Global Anti-Parkinson Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Global Anti-Parkinson Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Anti-Parkinson Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Anti-Parkinson Drugs Market Share by Region (2019-2024)
Table 10. Global Anti-Parkinson Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Anti-Parkinson Drugs Market Share by Region (2025-2030)
Table 12. Anti-Parkinson Drugs Market Trends
Table 13. Anti-Parkinson Drugs Market Drivers
Table 14. Anti-Parkinson Drugs Market Challenges
Table 15. Anti-Parkinson Drugs Market Restraints
Table 16. Global Anti-Parkinson Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Anti-Parkinson Drugs Revenue Share by Players (2019-2024)
Table 18. Global Top Anti-Parkinson Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Parkinson Drugs as of 2023)
Table 19. Global Anti-Parkinson Drugs Industry Ranking 2022 VS 2023 VS 2024
Table 20. Global 5 Largest Players Market Share by Anti-Parkinson Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Anti-Parkinson Drugs, Headquarters and Area Served
Table 22. Global Key Players of Anti-Parkinson Drugs, Product and Application
Table 23. Global Key Players of Anti-Parkinson Drugs, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti-Parkinson Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Anti-Parkinson Drugs Revenue Market Share by Type (2019-2024)
Table 27. Global Anti-Parkinson Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Anti-Parkinson Drugs Revenue Market Share by Type (2025-2030)
Table 29. Global Anti-Parkinson Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Anti-Parkinson Drugs Revenue Share by Application (2019-2024)
Table 31. Global Anti-Parkinson Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Anti-Parkinson Drugs Revenue Share by Application (2025-2030)
Table 33. North America Anti-Parkinson Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 34. North America Anti-Parkinson Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 35. North America Anti-Parkinson Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 36. North America Anti-Parkinson Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 37. North America Anti-Parkinson Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Anti-Parkinson Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Anti-Parkinson Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Anti-Parkinson Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 41. Europe Anti-Parkinson Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 42. Europe Anti-Parkinson Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 43. Europe Anti-Parkinson Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 44. Europe Anti-Parkinson Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Europe Anti-Parkinson Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Europe Anti-Parkinson Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. China Anti-Parkinson Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 48. China Anti-Parkinson Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 49. China Anti-Parkinson Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 50. China Anti-Parkinson Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 51. Asia Anti-Parkinson Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 52. Asia Anti-Parkinson Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 53. Asia Anti-Parkinson Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 54. Asia Anti-Parkinson Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 55. Asia Anti-Parkinson Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 56. Asia Anti-Parkinson Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 57. Asia Anti-Parkinson Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Anti-Parkinson Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Anti-Parkinson Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Anti-Parkinson Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Anti-Parkinson Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Anti-Parkinson Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 63. Middle East, Africa, and Latin America Anti-Parkinson Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Anti-Parkinson Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 65. AbbVie Company Details
Table 66. AbbVie Business Overview
Table 67. AbbVie Anti-Parkinson Drugs Product
Table 68. AbbVie Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 69. AbbVie Recent Developments
Table 70. Mylan Laboratories Company Details
Table 71. Mylan Laboratories Business Overview
Table 72. Mylan Laboratories Anti-Parkinson Drugs Product
Table 73. Mylan Laboratories Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 74. Mylan Laboratories Recent Developments
Table 75. Valeant Pharmaceuticals Company Details
Table 76. Valeant Pharmaceuticals Business Overview
Table 77. Valeant Pharmaceuticals Anti-Parkinson Drugs Product
Table 78. Valeant Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 79. Valeant Pharmaceuticals Recent Developments
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Anti-Parkinson Drugs Product
Table 83. Novartis Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 84. Novartis Recent Developments
Table 85. GlaxoSmithKline Company Details
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Anti-Parkinson Drugs Product
Table 88. GlaxoSmithKline Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 89. GlaxoSmithKline Recent Developments
Table 90. Zambon Pharmaceuticals Company Details
Table 91. Zambon Pharmaceuticals Business Overview
Table 92. Zambon Pharmaceuticals Anti-Parkinson Drugs Product
Table 93. Zambon Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 94. Zambon Pharmaceuticals Recent Developments
Table 95. Pfizer, Inc. Company Details
Table 96. Pfizer, Inc. Business Overview
Table 97. Pfizer, Inc. Anti-Parkinson Drugs Product
Table 98. Pfizer, Inc. Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 99. Pfizer, Inc. Recent Developments
Table 100. Hoffmann-La Roche Company Details
Table 101. Hoffmann-La Roche Business Overview
Table 102. Hoffmann-La Roche Anti-Parkinson Drugs Product
Table 103. Hoffmann-La Roche Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 104. Hoffmann-La Roche Recent Developments
Table 105. Merck & Co. Company Details
Table 106. Merck & Co. Business Overview
Table 107. Merck & Co. Anti-Parkinson Drugs Product
Table 108. Merck & Co. Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 109. Merck & Co. Recent Developments
Table 110. Orion Pharma Company Details
Table 111. Orion Pharma Business Overview
Table 112. Orion Pharma Anti-Parkinson Drugs Product
Table 113. Orion Pharma Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 114. Orion Pharma Recent Developments
Table 115. UCB Company Details
Table 116. UCB Business Overview
Table 117. UCB Anti-Parkinson Drugs Product
Table 118. UCB Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 119. UCB Recent Developments
Table 120. Teva Pharmaceutical Industries Ltd. Company Details
Table 121. Teva Pharmaceutical Industries Ltd. Business Overview
Table 122. Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Product
Table 123. Teva Pharmaceutical Industries Ltd. Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 124. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 125. Vertical Pharmaceuticals, LLC Company Details
Table 126. Vertical Pharmaceuticals, LLC Business Overview
Table 127. Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Product
Table 128. Vertical Pharmaceuticals, LLC Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 129. Vertical Pharmaceuticals, LLC Recent Developments
Table 130. ACADIA Pharmaceuticals Inc. Company Details
Table 131. ACADIA Pharmaceuticals Inc. Business Overview
Table 132. ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Product
Table 133. ACADIA Pharmaceuticals Inc. Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 134. ACADIA Pharmaceuticals Inc. Recent Developments
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Parkinson Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Anti-Parkinson Drugs Market Share by Type: 2023 VS 2030
Figure 3. Dopaminergic Features
Figure 4. Dopamine Agonists Features
Figure 5. Enzyme Inhibitors Features
Figure 6. Others Features
Figure 7. Global Anti-Parkinson Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Anti-Parkinson Drugs Market Share by Application: 2023 VS 2030
Figure 9. Hospital Pharmacy Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Online Stores Case Studies
Figure 12. Anti-Parkinson Drugs Report Years Considered
Figure 13. Global Anti-Parkinson Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Anti-Parkinson Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Anti-Parkinson Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Anti-Parkinson Drugs Market Share by Players in 2023
Figure 17. Global Top Anti-Parkinson Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Parkinson Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Anti-Parkinson Drugs Revenue in 2023
Figure 19. North America Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Anti-Parkinson Drugs Market Share by Type (2019-2030)
Figure 21. North America Anti-Parkinson Drugs Market Share by Application (2019-2030)
Figure 22. North America Anti-Parkinson Drugs Market Share by Country (2019-2030)
Figure 23. United States Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Anti-Parkinson Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 26. Europe Anti-Parkinson Drugs Market Share by Type (2019-2030)
Figure 27. Europe Anti-Parkinson Drugs Market Share by Application (2019-2030)
Figure 28. Europe Anti-Parkinson Drugs Market Share by Country (2019-2030)
Figure 29. Germany Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. China Anti-Parkinson Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 36. China Anti-Parkinson Drugs Market Share by Type (2019-2030)
Figure 37. China Anti-Parkinson Drugs Market Share by Application (2019-2030)
Figure 38. Asia Anti-Parkinson Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 39. Asia Anti-Parkinson Drugs Market Share by Type (2019-2030)
Figure 40. Asia Anti-Parkinson Drugs Market Share by Application (2019-2030)
Figure 41. Asia Anti-Parkinson Drugs Market Share by Region (2019-2030)
Figure 42. Japan Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. South Korea Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Taiwan Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. India Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Australia Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Anti-Parkinson Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Anti-Parkinson Drugs Market Share by Type (2019-2030)
Figure 50. Middle East, Africa, and Latin America Anti-Parkinson Drugs Market Share by Application (2019-2030)
Figure 51. Middle East, Africa, and Latin America Anti-Parkinson Drugs Market Share by Country (2019-2030)
Figure 52. Brazil Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Mexico Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Turkey Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Israel Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. GCC Countries Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. AbbVie Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 59. Mylan Laboratories Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 60. Valeant Pharmaceuticals Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 61. Novartis Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 63. Zambon Pharmaceuticals Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 64. Pfizer, Inc. Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 65. Hoffmann-La Roche Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 66. Merck & Co. Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 67. Orion Pharma Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 68. UCB Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 69. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 70. Vertical Pharmaceuticals, LLC Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 71. ACADIA Pharmaceuticals Inc. Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed